|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 加那索龙>> 市场分析报告 |
加那索龙市场分析报告 |
|
Global Market Report of GANAXOLONE (CAS 38398-32-2) December 2024 Ganaxolone - Emerging Insight and Market Forecast - 2030 ... Pharmaceuticals is developing convenient forms of ganaxolone – IV and oral – to ... databases. Ganaxolone Analytical Perspective by DelveInsight In-depth Ganaxolone Market ... cons (disadvantages) of Ganaxolone? In which countries Ganaxolone got approval and ... GABA A receptor agonist - Pipeline Insight, 2022 ... agonist Emerging Drugs Ganaxolone: Marinus Pharmaceuticals Ganaxolone is a GABAA receptor modulator ... the firing of the neuron. Ganaxolone is an analogue of the naturally ... Ovid Therapeutics Key Products Ganaxolone Padsevonil Acamprosate Darigabat Ciprofol ... GABA Receptor Agonists - Pipeline Insight, 2022 ... Agonists Emerging Drugs Ganaxolone: Marinus Pharmaceuticals Ganaxolone, a positive allosteric modulator of ... use of its lead product candidate ganaxolone, to treat seizures associated with ... Addex Therapeutics Key Products Ganaxolone EMB-001 XW10172 XP-0863 ... Refractory Status Epilepticus - Pipeline Insight, 2021 ... Status Epilepticus Emerging Drugs Ganaxolone: Marinus Pharmaceuticals Marinus Pharmaceuticals’ ... lead drug candidate, ganaxolone, is an orally administered small molecule in ... Pharma Solutions Key Products Ganaxolone JBPOS0101 Tuberous Sclerosis - Pipeline Insight, 2021 ... of patients with Tuberous sclerosis. Ganaxolone: Marinus Pharmaceuticals Ganaxolone is a GABAA receptor modulator that ... chief inhibitory neurotransmitter in the brain. Ganaxolone binds to one of the receptor subtypes ... Global Status Epilepticus Treatment Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 ... niche markets. Market segment by Type Ganaxolone Diazepam Fosphenytoin Valproate Phenobarbital Phenytoin ... Global Status Epilepticus Treatment Drugs Supply, Demand and Key Producers, 2023-2029 ... Treatment Drugs Market, Segmentation by Type Ganaxolone Diazepam Fosphenytoin Valproate Phenobarbital Phenytoin ... Epilepsy - Pipeline Insight, 2021 ... clinical trial to treat Epilepsy. Ganaxolone: Marinus Pharmaceuticals Ganaxolone is a GABAA receptor modulator that ... activity in other CNS disorders. Because ganaxolone modulates both synaptic and extrasynaptic ... Lennox-Gastaut Syndrome (LGS) - Pipeline Insight, 2021 ... Pharmaceuticals Key Products Soticlestat Fenfluramine Ganaxolone Carisbamate NRP 2945 TAH-6601 ... Epilepsy: Disease Inights and Market Forecasts to 2024 Delivery time for this report is 5 days “Epilepsy: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Epilepsy disease in the US, EU5 (Germany, France, Italy, ... Fragile X Syndrome – Pipeline Insight, 2020 ... BPN14770 AUT00206 Pridopidine MG01CI Arbaclofen Ganaxolone AFQ056 NNZ-2566 RO4917523 Epilepsy: Pipeline Assessment and Insights Delivery time for this report is 2-3 days “Epilepsy: Pipeline Assessment and Insights” report delivers an in-depth understanding of the disease, highlights all the pipeline products in different phases of development for the disease including the Suspended ... Refractory Epilepsy- Pipeline Insight, 2019 This report can be delivered to the clients within 24 Hours "Refractory Epilepsy- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the ... Global Status Epilepticus Treatment Drugs Market Research Report 2024(Status and Outlook) ... Pharmaceuticals H. Lundbeck Market Segmentation (by Type) Ganaxolone Diazepam Fosphenytoin Valproate Phenobarbital Phenytoin ... Epilepsy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major epilepsy markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of 2.35% during 2024-2034. The epilepsy market has been comprehensively ... Neurocutaneous Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major neurocutaneous syndromes markets are expected to exhibit a CAGR of 6.63% during 2024-2034 The neurocutaneous syndromes market has been comprehensively analyzed in IMARC's new report titled "Neurocutaneous Syndromes Market: Epidemiology, ... Status Epilepticus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major status epilepticus markets reached a value of US$ 884 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,338.0 Million by 2034, exhibiting a growth rate (CAGR) of 3.84% during 2024-2034. The status epilepticus market ... Global Epilepsy Drugs Market - 2025-2033 ... , Inc. disclosed that its ZTALMY (ganaxolone) oral suspension received approval from ... Refractory Epilepsy Treatment Market - A Global and Regional Analysis: Focus on Treatment Type, Patient Type, Seizure Type, Distribution Channel, and Regional Analysis - Analysis and Forecast, 2025-2035 This report can be delivered within 1 working day. Introduction of Refractory Epilepsy Treatment Refractory epilepsy treatment utilizes an individual's distinct clinical, molecular, and lifestyle data to inform the diagnosis, treatment, and prevention of ... |